Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.80

-0.02 (-1.10%)

As of May 16, 2:17 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,569.4% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $1.80

Current
$1.80

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

1,128.9%

Low target

Base Case

$30.05

+1,569.4%

Avg target

Bull Case

$38.96

+2,064.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-58.5% from high

52-Week Low

$1.41

+27.7% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%